img

Global Hepatitis A and B Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hepatitis A and B Vaccine Market Research Report 2024

The hepatitis A and hepatitis B vaccines can be given separately or as a combination vaccine. All the shots in the series are needed for long-term protection. The full series of the hepatitis A and hepatitis B vaccines require 2-3 shots, depending on the type of vaccine.
According to Mr Accuracy reports new survey, global Hepatitis A and B Vaccine market is projected to reach US$ 2037.4 million in 2029, increasing from US$ 1798.9 million in 2022, with the CAGR of 1.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hepatitis A and B Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hepatitis A and B Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
NCPC
Bio Kangtai
Dynavax
Hissen
LG Life Sciences
Serum Institute
Segment by Type
Hepatitis A Vaccination
Hepatitis B Vaccination

Segment by Application


Government Institution
Private Sector
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Hepatitis A and B Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Hepatitis A and B Vaccine Market Overview
1.1 Product Overview and Scope of Hepatitis A and B Vaccine
1.2 Hepatitis A and B Vaccine Segment by Type
1.2.1 Global Hepatitis A and B Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Hepatitis A Vaccination
1.2.3 Hepatitis B Vaccination
1.3 Hepatitis A and B Vaccine Segment by Application
1.3.1 Global Hepatitis A and B Vaccine Market Value by Application: (2024-2034)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A and B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Hepatitis A and B Vaccine Revenue 2018-2029
1.4.2 Global Hepatitis A and B Vaccine Sales 2018-2029
1.4.3 Global Hepatitis A and B Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hepatitis A and B Vaccine Market Competition by Manufacturers
2.1 Global Hepatitis A and B Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Hepatitis A and B Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Hepatitis A and B Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Hepatitis A and B Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Hepatitis A and B Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis A and B Vaccine, Product Type & Application
2.7 Hepatitis A and B Vaccine Market Competitive Situation and Trends
2.7.1 Hepatitis A and B Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatitis A and B Vaccine Players Market Share by Revenue
2.7.3 Global Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis A and B Vaccine Retrospective Market Scenario by Region
3.1 Global Hepatitis A and B Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hepatitis A and B Vaccine Global Hepatitis A and B Vaccine Sales by Region: 2018-2029
3.2.1 Global Hepatitis A and B Vaccine Sales by Region: 2018-2024
3.2.2 Global Hepatitis A and B Vaccine Sales by Region: 2024-2029
3.3 Global Hepatitis A and B Vaccine Global Hepatitis A and B Vaccine Revenue by Region: 2018-2029
3.3.1 Global Hepatitis A and B Vaccine Revenue by Region: 2018-2024
3.3.2 Global Hepatitis A and B Vaccine Revenue by Region: 2024-2029
3.4 North America Hepatitis A and B Vaccine Market Facts & Figures by Country
3.4.1 North America Hepatitis A and B Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hepatitis A and B Vaccine Sales by Country (2018-2029)
3.4.3 North America Hepatitis A and B Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis A and B Vaccine Market Facts & Figures by Country
3.5.1 Europe Hepatitis A and B Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hepatitis A and B Vaccine Sales by Country (2018-2029)
3.5.3 Europe Hepatitis A and B Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis A and B Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatitis A and B Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hepatitis A and B Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Hepatitis A and B Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hepatitis A and B Vaccine Market Facts & Figures by Country
3.7.1 Latin America Hepatitis A and B Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hepatitis A and B Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Hepatitis A and B Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis A and B Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis A and B Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hepatitis A and B Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hepatitis A and B Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis A and B Vaccine Sales by Type (2018-2029)
4.1.1 Global Hepatitis A and B Vaccine Sales by Type (2018-2024)
4.1.2 Global Hepatitis A and B Vaccine Sales by Type (2024-2029)
4.1.3 Global Hepatitis A and B Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Hepatitis A and B Vaccine Revenue by Type (2018-2029)
4.2.1 Global Hepatitis A and B Vaccine Revenue by Type (2018-2024)
4.2.2 Global Hepatitis A and B Vaccine Revenue by Type (2024-2029)
4.2.3 Global Hepatitis A and B Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Hepatitis A and B Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Hepatitis A and B Vaccine Sales by Application (2018-2029)
5.1.1 Global Hepatitis A and B Vaccine Sales by Application (2018-2024)
5.1.2 Global Hepatitis A and B Vaccine Sales by Application (2024-2029)
5.1.3 Global Hepatitis A and B Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Hepatitis A and B Vaccine Revenue by Application (2018-2029)
5.2.1 Global Hepatitis A and B Vaccine Revenue by Application (2018-2024)
5.2.2 Global Hepatitis A and B Vaccine Revenue by Application (2024-2029)
5.2.3 Global Hepatitis A and B Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Hepatitis A and B Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 GSK Hepatitis A and B Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Merck Hepatitis A and B Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Sanofi Hepatitis A and B Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sinovac
6.4.1 Sinovac Corporation Information
6.4.2 Sinovac Description and Business Overview
6.4.3 Sinovac Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sinovac Hepatitis A and B Vaccine Product Portfolio
6.4.5 Sinovac Recent Developments/Updates
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Corporation Information
6.5.2 Zhejiang Pukang Description and Business Overview
6.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Zhejiang Pukang Hepatitis A and B Vaccine Product Portfolio
6.5.5 Zhejiang Pukang Recent Developments/Updates
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Changchun Institute of Biological Hepatitis A and B Vaccine Product Portfolio
6.6.5 Changchun Institute of Biological Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 KM Biologics Hepatitis A and B Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 IMBCAMS
6.8.1 IMBCAMS Corporation Information
6.8.2 IMBCAMS Description and Business Overview
6.8.3 IMBCAMS Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 IMBCAMS Hepatitis A and B Vaccine Product Portfolio
6.8.5 IMBCAMS Recent Developments/Updates
6.9 Convac
6.9.1 Convac Corporation Information
6.9.2 Convac Description and Business Overview
6.9.3 Convac Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Convac Hepatitis A and B Vaccine Product Portfolio
6.9.5 Convac Recent Developments/Updates
6.10 NCPC
6.10.1 NCPC Corporation Information
6.10.2 NCPC Description and Business Overview
6.10.3 NCPC Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 NCPC Hepatitis A and B Vaccine Product Portfolio
6.10.5 NCPC Recent Developments/Updates
6.11 Bio Kangtai
6.11.1 Bio Kangtai Corporation Information
6.11.2 Bio Kangtai Hepatitis A and B Vaccine Description and Business Overview
6.11.3 Bio Kangtai Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Bio Kangtai Hepatitis A and B Vaccine Product Portfolio
6.11.5 Bio Kangtai Recent Developments/Updates
6.12 Dynavax
6.12.1 Dynavax Corporation Information
6.12.2 Dynavax Hepatitis A and B Vaccine Description and Business Overview
6.12.3 Dynavax Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Dynavax Hepatitis A and B Vaccine Product Portfolio
6.12.5 Dynavax Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Corporation Information
6.13.2 Hissen Hepatitis A and B Vaccine Description and Business Overview
6.13.3 Hissen Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Hissen Hepatitis A and B Vaccine Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 LG Life Sciences
6.14.1 LG Life Sciences Corporation Information
6.14.2 LG Life Sciences Hepatitis A and B Vaccine Description and Business Overview
6.14.3 LG Life Sciences Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 LG Life Sciences Hepatitis A and B Vaccine Product Portfolio
6.14.5 LG Life Sciences Recent Developments/Updates
6.15 Serum Institute
6.15.1 Serum Institute Corporation Information
6.15.2 Serum Institute Hepatitis A and B Vaccine Description and Business Overview
6.15.3 Serum Institute Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Serum Institute Hepatitis A and B Vaccine Product Portfolio
6.15.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis A and B Vaccine Industry Chain Analysis
7.2 Hepatitis A and B Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis A and B Vaccine Production Mode & Process
7.4 Hepatitis A and B Vaccine Sales and Marketing
7.4.1 Hepatitis A and B Vaccine Sales Channels
7.4.2 Hepatitis A and B Vaccine Distributors
7.5 Hepatitis A and B Vaccine Customers
8 Hepatitis A and B Vaccine Market Dynamics
8.1 Hepatitis A and B Vaccine Industry Trends
8.2 Hepatitis A and B Vaccine Market Drivers
8.3 Hepatitis A and B Vaccine Market Challenges
8.4 Hepatitis A and B Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Hepatitis A and B Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Hepatitis A and B Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Hepatitis A and B Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Hepatitis A and B Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Hepatitis A and B Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Hepatitis A and B Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Hepatitis A and B Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Hepatitis A and B Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Hepatitis A and B Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Hepatitis A and B Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis A and B Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis A and B Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis A and B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A and B Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis A and B Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Hepatitis A and B Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Hepatitis A and B Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Hepatitis A and B Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Hepatitis A and B Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Hepatitis A and B Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Hepatitis A and B Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Hepatitis A and B Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Hepatitis A and B Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Hepatitis A and B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Hepatitis A and B Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Hepatitis A and B Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Hepatitis A and B Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Hepatitis A and B Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Hepatitis A and B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Hepatitis A and B Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Hepatitis A and B Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Hepatitis A and B Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Hepatitis A and B Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Hepatitis A and B Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Hepatitis A and B Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Hepatitis A and B Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Hepatitis A and B Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Hepatitis A and B Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Hepatitis A and B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Hepatitis A and B Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Hepatitis A and B Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Hepatitis A and B Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Hepatitis A and B Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hepatitis A and B Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Hepatitis A and B Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Hepatitis A and B Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Hepatitis A and B Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Hepatitis A and B Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Hepatitis A and B Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Hepatitis A and B Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Hepatitis A and B Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Hepatitis A and B Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Hepatitis A and B Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Hepatitis A and B Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Hepatitis A and B Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Hepatitis A and B Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Hepatitis A and B Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Hepatitis A and B Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Hepatitis A and B Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Hepatitis A and B Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Hepatitis A and B Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Hepatitis A and B Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Hepatitis A and B Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Hepatitis A and B Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Hepatitis A and B Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Hepatitis A and B Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Hepatitis A and B Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Hepatitis A and B Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. GSK Hepatitis A and B Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Merck Hepatitis A and B Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Sanofi Hepatitis A and B Vaccine Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Sinovac Corporation Information
Table 86. Sinovac Description and Business Overview
Table 87. Sinovac Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Sinovac Hepatitis A and B Vaccine Product
Table 89. Sinovac Recent Developments/Updates
Table 90. Zhejiang Pukang Corporation Information
Table 91. Zhejiang Pukang Description and Business Overview
Table 92. Zhejiang Pukang Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Zhejiang Pukang Hepatitis A and B Vaccine Product
Table 94. Zhejiang Pukang Recent Developments/Updates
Table 95. Changchun Institute of Biological Corporation Information
Table 96. Changchun Institute of Biological Description and Business Overview
Table 97. Changchun Institute of Biological Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Changchun Institute of Biological Hepatitis A and B Vaccine Product
Table 99. Changchun Institute of Biological Recent Developments/Updates
Table 100. KM Biologics Corporation Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. KM Biologics Hepatitis A and B Vaccine Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. IMBCAMS Corporation Information
Table 106. IMBCAMS Description and Business Overview
Table 107. IMBCAMS Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. IMBCAMS Hepatitis A and B Vaccine Product
Table 109. IMBCAMS Recent Developments/Updates
Table 110. Convac Corporation Information
Table 111. Convac Description and Business Overview
Table 112. Convac Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Convac Hepatitis A and B Vaccine Product
Table 114. Convac Recent Developments/Updates
Table 115. NCPC Corporation Information
Table 116. NCPC Description and Business Overview
Table 117. NCPC Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. NCPC Hepatitis A and B Vaccine Product
Table 119. NCPC Recent Developments/Updates
Table 120. Bio Kangtai Corporation Information
Table 121. Bio Kangtai Description and Business Overview
Table 122. Bio Kangtai Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Bio Kangtai Hepatitis A and B Vaccine Product
Table 124. Bio Kangtai Recent Developments/Updates
Table 125. Dynavax Corporation Information
Table 126. Dynavax Description and Business Overview
Table 127. Dynavax Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Dynavax Hepatitis A and B Vaccine Product
Table 129. Dynavax Recent Developments/Updates
Table 130. Hissen Corporation Information
Table 131. Hissen Description and Business Overview
Table 132. Hissen Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Hissen Hepatitis A and B Vaccine Product
Table 134. Hissen Recent Developments/Updates
Table 135. LG Life Sciences Corporation Information
Table 136. LG Life Sciences Description and Business Overview
Table 137. LG Life Sciences Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. LG Life Sciences Hepatitis A and B Vaccine Product
Table 139. LG Life Sciences Recent Developments/Updates
Table 140. Serum Institute Corporation Information
Table 141. Serum Institute Description and Business Overview
Table 142. Serum Institute Hepatitis A and B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Serum Institute Hepatitis A and B Vaccine Product
Table 144. Serum Institute Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Hepatitis A and B Vaccine Distributors List
Table 148. Hepatitis A and B Vaccine Customers List
Table 149. Hepatitis A and B Vaccine Market Trends
Table 150. Hepatitis A and B Vaccine Market Drivers
Table 151. Hepatitis A and B Vaccine Market Challenges
Table 152. Hepatitis A and B Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis A and B Vaccine
Figure 2. Global Hepatitis A and B Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Hepatitis A and B Vaccine Market Share by Type in 2022 & 2029
Figure 4. Hepatitis A Vaccination Product Picture
Figure 5. Hepatitis B Vaccination Product Picture
Figure 6. Global Hepatitis A and B Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Hepatitis A and B Vaccine Market Share by Application in 2022 & 2029
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Global Hepatitis A and B Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Hepatitis A and B Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Hepatitis A and B Vaccine Sales (2018-2029) & (K Units)
Figure 14. Global Hepatitis A and B Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 15. Hepatitis A and B Vaccine Report Years Considered
Figure 16. Hepatitis A and B Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Hepatitis A and B Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Hepatitis A and B Vaccine Players: Market Share by Revenue in 2022
Figure 19. Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Hepatitis A and B Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Hepatitis A and B Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America Hepatitis A and B Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. United States Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Hepatitis A and B Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe Hepatitis A and B Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Hepatitis A and B Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Hepatitis A and B Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Hepatitis A and B Vaccine Sales Market Share by Country (2018-2029)
Figure 44. Latin America Hepatitis A and B Vaccine Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Hepatitis A and B Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Hepatitis A and B Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Hepatitis A and B Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Hepatitis A and B Vaccine by Type (2018-2029)
Figure 54. Global Revenue Market Share of Hepatitis A and B Vaccine by Type (2018-2029)
Figure 55. Global Hepatitis A and B Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Hepatitis A and B Vaccine by Application (2018-2029)
Figure 57. Global Revenue Market Share of Hepatitis A and B Vaccine by Application (2018-2029)
Figure 58. Global Hepatitis A and B Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 59. Hepatitis A and B Vaccine Value Chain
Figure 60. Hepatitis A and B Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed